位阻效应
配体(生物化学)
化学
亲核细胞
催化作用
电泳剂
组合化学
计算化学
芳基
分子
卤化物
反应性(心理学)
卤代芳基
有机合成
戒指(化学)
密度泛函理论
联轴节(管道)
锡
纳米技术
立体化学
偶联反应
化学物理
均相催化
设计要素和原则
作者
Aleksander R. Bena,Trisha Banik,Christos Giannoudis,Florian Ortis,Daniel Bím,Haralds Baunis,Gayathri H. Palissery,Bartholomäus Pieber
出处
期刊:
日期:2025-11-11
被引量:2
标识
DOI:10.26434/chemrxiv-2025-1czpp-v2
摘要
The formation of C(sp2)–heteroatom bonds is a cornerstone of modern organic synthesis and key for the preparation of pharmaceuticals, agrochemicals, and functional materials. Traditionally, such bond formations have relied on palladium-catalyzed cross-couplings operating through canonical Pd0/PdII cycles, which require complex ligand architectures to control the orthogonal steric and electronic ligand demands for the initial electrophile activation and final bond forming event.Cross-coupling catalysis via paramagnetic Niᴵ and Niᴵᴵᴵ species is an appealing alternative because the bond-forming step is energetically favorable. However, this approach is confined to activated starting materials and requires high catalyst loadings, due to the insufficient catalytic activity and stability of state-of-the-art NiI catalysts. Here, we show that mechanistically guided ligand design overcomes these intrinsic bottlenecks by achieving a well-balanced equilibrium between a highly reactive NiI species and a stabilized ligand-centered radical. Use of a non-nucleophilic base additive promotes visible-light generation of Niᴵ from a bench-stable precatalyst and facilitates reactions with a broad range of nucleophiles. Our results show that this platform provides a highly general set of conditions for coupling challenging aryl halides with N-, O-, S-, and P-based nucleophiles at nickel loadings as low as 100 ppm. Further, this is the first NiI/NiIII catalysis method that couples sterically encumbered nucleophiles. Gram-scale synthesis of pharmaceuticals and late-stage couplings of complex molecules underscore the potential of this approach for medicinal chemistry applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI